ArticleBiology of sex differences2026
Sex differences in proteomic response to ischemic stroke.
Article in Biology of sex differences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundWomen often experience greater disability after ischemic stroke than men, but the biological mechanisms underlying these differences remain unclear. Proteomic analysis may identify sex-specific molecular pathways that contribute to stroke rehabilitation and recovery.
methodsWe analyzed plasma samples from 141 patients enrolled in the Blood and Clot Thrombectomy Registry and Collaboration (BACTRAC). Expression of 184 inflammatory and cardiometabolic proteins, measured proximal and distal to the clot, was quantified using Olink panels. Associations between protein expression and discharge outcomes - including the National Institutes of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS), and Montreal Cognitive Assessment (MoCA) - were evaluated with models including a sex by protein interaction term, adjusting for clinical and demographic covariates.
resultsThe median age was 69 years, and 55% were women. After controlling the false discovery rate, systemic TGFBI was expressed at higher levels in men. Multiple proteins demonstrated sex-specific associations with discharge outcomes. For NIHSS, systemic PCOLCE and NT3, as well as intracranial FGF5, NT3, TNFSF14, and TWEAK, were differentially associated by sex, with higher expression generally linked to worse outcomes in women and protective trends in men. For mRS, systemic ICAM3 and TGFBI were associated with higher odds of poor mRS scores in women, while SELL showed a potential protective effect in men. Intracranial CD6 and LAP TGF-β1 also demonstrated sex-specific associations with mRS scores. No sex-specific associations were observed for MoCA.
conclusionsSeveral sex dependent proteins were associated with post-stroke discharge outcomes. These findings suggest that sex-specific molecular responses could contribute to disparities in post-stroke recovery and highlight the importance of incorporating sex as a biological variable in biomarker studies as well as stratifying clinical trials based on sex.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.